| For: | Bose SK, Ray R. Hepatitis C virus infection and insulin resistance. World J Diabetes 2014; 5(1): 52-58 [PMID: 24567801 DOI: 10.4239/wjd.v5.i1.52] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v5/i1/52.htm |
| Number | Citing Articles |
| 1 |
Vincenza Frisardi. Commentary: Coronavirus and Obesity: Could Insulin Resistance Mediate the Severity of Covid-19 Infection?. Frontiers in Public Health 2020; 8 doi: 10.3389/fpubh.2020.00351
|
| 2 |
Praveen Raman Mishra, Akash Bharti, Ridhi Arora, Irfan Ahmad Mir, V. P. S. Punia. Increased Insulin Resistance in Hepatitis-C Infection—Association with Altered Hepatic Function Testing. Pathophysiology 2022; 29(3) doi: 10.3390/pathophysiology29030024
|
| 3 |
Che C. Colpitts, Hussein El-Saghire, Nathalie Pochet, Catherine Schuster, Thomas F. Baumert. High-throughput approaches to unravel hepatitis C virus-host interactions. Virus Research 2016; 218 doi: 10.1016/j.virusres.2015.09.013
|
| 4 |
Nabeel Alzahrani. Hepatitis C virus, insulin resistance, and diabetes: A review. Microbiology and Immunology 2022; 66(10) doi: 10.1111/1348-0421.13023
|
| 5 |
Busara Songtanin, Kenneth Nugent. Burden, Outcome, and Comorbidities of Extrahepatic Manifestations in Hepatitis C Virus Infection. Biology 2022; 12(1) doi: 10.3390/biology12010023
|
| 6 |
Yasuhiro Matsue, Mikihiro Tsutsumi, Nobuhiko Hayashi, Takashi Saito, Mutsumi Tsuchishima, Nobuyuki Toshikuni, Tomiyasu Arisawa, Joseph George, Ratna B. Ray. Serum Osteopontin Predicts Degree of Hepatic Fibrosis and Serves as a Biomarker in Patients with Hepatitis C Virus Infection. PLOS ONE 2015; 10(3) doi: 10.1371/journal.pone.0118744
|
| 7 |
So Mi Kim, Il Han Song. Hepatitis C virus infection in chronic kidney disease: paradigm shift in management. The Korean Journal of Internal Medicine 2018; 33(4) doi: 10.3904/kjim.2018.202
|
| 8 |
Juli Bai, Feng Liu. The cGAS-cGAMP-STING Pathway: A Molecular Link Between Immunity and Metabolism. Diabetes 2019; 68(6) doi: 10.2337/dbi18-0052
|
| 9 |
Mahmoud M. Elnokeety, Rasha Ahmed Darwish, Mohamed Tharwat Hegazy, Sameh Abouzeid, Ahmed Fayed. The impact of HCV eradication using interferon-free direct acting antivirals on bone-mineral, anemia parameters and peripheral insulin resistance in hepatitis c-infected Egyptian hemodialysis cohort. Renal Replacement Therapy 2023; 9(1) doi: 10.1186/s41100-023-00500-4
|
| 10 |
Dan Li, Yang Jiao, Haiwei Yu, Sijian Feng. Cardiovascular Manifestations of Viral Hepatitis: A Systematic Review and Meta-Analysis. Hepatitis Monthly 2026; 26(1) doi: 10.5812/hepatmon-167192
|
| 11 |
Shyam Patel, Laura Bull, Kian Salimi, Amy M. Shui, Kevin Siao, Bokun Yang, Jacquelyn J. Maher, Mandana Khalili. Exploring the impact of graded alcohol use on atherogenic lipid profiles among Latinos with underlying chronic liver disease. Alcohol, Clinical and Experimental Research 2025; 49(4) doi: 10.1111/acer.70010
|
| 12 |
. 2014; doi: 10.70675/a821800cz5289z4336z8ea8z35747d5bec05
|
| 13 |
Raoni Freitas Carvalho, Ajax Mercês Atta, Isabela Silva de Oliveira, Taciana Pereira Sant’Ana Santos, João Pedro A. Santos, Maria Isabel Schinoni, Maria Luiza Brito de Sousa-Atta. Adiponectin levels and insulin resistance among patients with chronic hepatitis C. Acta Tropica 2018; 178 doi: 10.1016/j.actatropica.2017.12.004
|
| 14 |
Blake A. Niccum, Jonathan G. Stine, Javelle A. Wynter, Virginia Kelly, Stephen H. Caldwell, Neeral L. Shah. Success of Direct-Acting, Antiviral-Based Therapy for Chronic Hepatitis C Is Not Affected by Type 2 Diabetes. Clinical Diabetes 2020; 38(1) doi: 10.2337/cd18-0112
|
| 15 |
Dr Tufael, Mohd Hasan Mujahid, Most Farhana Akter, Tahsin Salam, Md Abu Bakar Siddique, Kaniz Fatima Bari, Asim Debnath, Nabil Deb Nath, Yury E Khudyakov. The role of insulin resistance in the development of hepatocellular carcinoma with computational analysis of IRS-1 interaction with HCV genotype 3 core protein. PLOS One 2026; 21(9) doi: 10.1371/journal.pone.0358858
|
| 16 |
M.A. Shawky, A.Q. Mohammed, A.M. Hassan, B.H. Ali, H.M. Moustafa. Resistencia a la insulina en pacientes egipcios no diabéticos infectados con el virus de hepatitis C crónica. Revista de Gastroenterología de México 2020; 85(2) doi: 10.1016/j.rgmx.2019.05.005
|
| 17 |
Ahmed S. Yousef, Alaliaa M. Sallam, Nahla S. kotb, Hala O. El-Mesallamy. The association of Fat Mass and Obesity-Associated (FTO) gene polymorphism (rs9939609) with metabolic disturbances and response to sofosbuvir, ribavirin and interferon triple therapy in patients with viral hepatitis C. Meta Gene 2021; 28 doi: 10.1016/j.mgene.2021.100888
|
| 18 |
Bing Chen, Umair Iqbal, Shivani K. Desai, Jacob Gries, Elijah Verheyen, Mengdan Xie, Maan El Halabi, Sara Gaines, Ilan Weisberg. The role of treatment of hepatitis C with direct‐acting antiviral agents on glycaemic control in diabetic patients: An updated systematic review and meta‐analysis. Journal of Viral Hepatitis 2024; 31(10) doi: 10.1111/jvh.13984
|
| 19 |
EL Shaimaa Gomaa Ali, Rasha H. Bassyouni, Omayma O. Abdelaleem, Essam A. Hassan, Sylvana N. Gaber. Association between SNPs of Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), programmed cell death 1 (PD-1)and the susceptibility to chronic Hepatitis C infection in virus C-infected patients. Virus Research 2022; 310 doi: 10.1016/j.virusres.2022.198684
|
| 20 |
N. K. T. Hlaing, R. A. Mitrani, S. T. Aung, W. W. Phyo, M. Serper, A. M. M. Kyaw, A. H. Bwa, K. M. Win, K. R. Reddy. Safety and efficacy of sofosbuvir‐based direct‐acting antiviral regimens for hepatitis C virus genotypes 1‐4 and 6 in Myanmar: Real‐world experience. Journal of Viral Hepatitis 2017; 24(11) doi: 10.1111/jvh.12721
|
| 21 |
Thanathip Suenghataiphorn, Narisara Tribhuddharat, Pojsakorn Danpanichkul, Thitiphan Srikulmontri, Narathorn Kulthamrongsri. Hepatitis C increases acute myocardial infarction risk in people living with HIV: A systematic review and meta-analysis. International Journal of STD & AIDS 2025; 36(10) doi: 10.1177/09564624251348688
|
| 22 |
Amirhossein Shahpar, Vahideh Hamidi Sofiani, Nazanin Zeinali Nezhad, Marzieh Charostad, Reza Ghaderi, Niloofar Farsiu, Amin Karimzadeh Kiskani, Sara Pezeshki, Mohsen Nakhaie. A narrative review: exploring viral-induced malignancies through the lens of dysregulated cellular metabolism and glucose transporters. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-13013-y
|
| 23 |
Geneviève F. Desrochers, Allison R. Sherratt, David R. Blais, Neda Nasheri, Zhibin Ning, Daniel Figeys, Natalie K. Goto, John Paul Pezacki. Profiling Kinase Activity during Hepatitis C Virus Replication Using a Wortmannin Probe. ACS Infectious Diseases 2015; 1(9) doi: 10.1021/acsinfecdis.5b00083
|
| 24 |
Ayman Alsebaey, Mostafa Elhelbawy. Insulin resistance is not a risk factor for oesophageal varices development in hepatitis C. Tropical Doctor 2019; 49(4) doi: 10.1177/0049475519863231
|
| 25 |
Luciana D. Silva, Tatiana Bering, Gifone A. Rocha. The impact of nutrition on quality of life of patients with hepatitis C. Current Opinion in Clinical Nutrition & Metabolic Care 2017; 20(5) doi: 10.1097/MCO.0000000000000396
|
| 26 |
Saeeda Fouzia Qasim, Ajmaal Jami, Paras Imran, Romana Mushtaque, Rashid Naseem Khan. Frequency of Metabolic Syndrome in Chronic Hepatitis C Patients: Findings From a Lower Middle Income Country. Cureus 2020; doi: 10.7759/cureus.11975
|
| 27 |
Gantsetseg Gantumur, Batbold Batsaikhan, Ching-I Huang, Ming-Lun Yeh, Chung-Feng Huang, Yi-Hung Lin, Tzu-Chun Lin, Po-Cheng Liang, Ta-Wei Liu, Jia-Jung Lee, Yi-Ching Lin, I-Ling Lin, Jee-Fu Huang, Wan-Long Chuang, Ming-Lung Yu, Hung-Pin Tu, Chia-Yen Dai. The association between hepatitis C virus infection and renal function. Journal of the Chinese Medical Association 2021; 84(8) doi: 10.1097/JCMA.0000000000000561
|
| 28 |
Yuki Haga, Tatsuo Kanda, Reina Sasaki, Masato Nakamura, Shingo Nakamoto, Osamu Yokosuka. Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis. World Journal of Gastroenterology 2015; 21(46): 12989-12995 doi: 10.3748/wjg.v21.i46.12989
|
| 29 |
Alaaeldin Abdelsalam Dawood, Mohamed Zakarya Nooh, Ayman Abdelhaleem Elgamal. Factors Associated with Improved Glycemic Control by Direct-Acting Antiviral Agent Treatment in Egyptian Type 2 Diabetes Mellitus Patients with Chronic Hepatitis C Genotype 4. Diabetes & Metabolism Journal 2017; 41(4) doi: 10.4093/dmj.2017.41.4.316
|
| 30 |
Diego García-Compeán, Emanuela Orsi, Ramesh Kumar, Felix Gundling, Tsutomu Nishida, Jesús Zacarías Villarreal-Pérez, Ángel N Del Cueto-Aguilera, José A González-González, Giuseppe Pugliese. Clinical implications of diabetes in chronic liver disease: Diagnosis, outcomes and management, current and future perspectives. World Journal of Gastroenterology 2022; 28(8): 775-793 doi: 10.3748/wjg.v28.i8.775
|
| 31 |
Ammon Handisurya, Corinna Kerscher, Andrea Tura, Harald Herkner, Berit Anna Payer, Mattias Mandorfer, Johannes Werzowa, Wolfgang Winnicki, Thomas Reiberger, Alexandra Kautzky-Willer, Giovanni Pacini, Marcus Säemann, Alice Schmidt, Jose Ignacio Herrero. Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients. PLOS ONE 2016; 11(1) doi: 10.1371/journal.pone.0145319
|
| 32 |
Pin-Nan Cheng, Hung-Yu Sun, I-Che Feng, Yen-Cheng Chiu, Sin-Tian Wang, Dyoness Charmaine Tan, Hung-Chih Chiu, Shih-Chih Chien, Kung-Chia Young. Interdependence of glycemic and lipid modulation in cured chronic hepatitis C patients by direct-acting antiviral agents. Journal of Microbiology, Immunology and Infection 2023; 56(1) doi: 10.1016/j.jmii.2022.06.004
|
| 33 |
Jing Liang, Chaoyang Lv, Minling Chen, Ming Xu, Chenhe Zhao, Yinqiu Yang, Jina Wang, Dong Zhu, Jian Gao, Ruiming Rong, Tongyu Zhu, Mingxiang Yu. Effects of preoperative hepatitis B virus infection, hepatitis C virus infection, and coinfection on the development of new‐onset diabetes after kidney transplantation. Journal of Diabetes 2019; 11(5) doi: 10.1111/1753-0407.12853
|
| 34 |
Felix Gundling. Der hepatogene Diabetes – aktueller Stand der Diagnostik und Therapie. Journal für Klinische Endokrinologie und Stoffwechsel 2022; 15(2) doi: 10.1007/s41969-022-00158-z
|
| 35 |
Feray Ferda Senol, Ilkay Bahcecı, Sermin Algül, Ozlem Aytac, Arzu Şenol, Yusuf Çelik. Investigation of Changes in Irisin and Nesfatin-1 Levels in Chronic Viral Hepatitis. Journal of Clinical Medicine 2026; 15(9) doi: 10.3390/jcm15093209
|
| 36 |
Wael A H Hegazy, Azza A H Rajab, Amr S Abu Lila, Hisham A Abbas. Anti-diabetics and antimicrobials: Harmony of mutual interplay. World Journal of Diabetes 2021; 12(11): 1832-1855 doi: 10.4239/wjd.v12.i11.1832
|
| 37 |
Mohamed M. Salama, Manal M. Nomir, Maryan W. Fahmi, Amal M. El-Gayar, Mamdouh M. El-Shishtawy. Potential Role of Microfibrillar-Associated Protein 4, Fibrotic Indices and Oxidative Stress in Hepatocellular Carcinoma. Scientia Pharmaceutica 2018; 86(4) doi: 10.3390/scipharm86040044
|
| 38 |
Z A Kalmykova, I V Kononenko, A Yu Mayorov. Diabetes mellitus and chronic liver diseases. Part 1: general mechanisms of etiology and pathogenesis. Terapevticheskii arkhiv 2019; 91(10) doi: 10.26442/00403660.2019.10.000165
|
| 39 |
Benli Jia, Dongsheng Yu, Gang Yu, Yunsheng Cheng, Yang Wang, Xiaoqiang Yi, Xiaoping Li, Yong Wang. Naringenin improve hepatitis C virus infection induced insulin resistance by increase PTEN expression via p53-dependent manner. Biomedicine & Pharmacotherapy 2018; 103 doi: 10.1016/j.biopha.2018.04.110
|
| 40 |
Raymond Anthony Pashun, Nicole T. Shen, Arun Jesudian. Markedly Improved Glycemic Control in Poorly Controlled Type 2 Diabetes following Direct Acting Antiviral Treatment of Genotype 1 Hepatitis C. Case Reports in Hepatology 2016; 2016 doi: 10.1155/2016/7807921
|
| 41 |
Rahma Mohamed, Aya M. Abdelmagid, Amani M. Ali, Ahmed M. Kamel, Ahmed Cordie. Beyond viral elimination: the emerging epidemic of metabolic dysfunction-associated steatotic liver disease (MASLD)–viral hepatitis overlap. Arab Journal of Gastroenterology 2026; 27(2) doi: 10.1016/j.ajg.2026.02.001
|
| 42 |
Gesche K. Gerresheim, Elke Roeb, Audrey M. Michel, Michael Niepmann. Hepatitis C Virus Downregulates Core Subunits of Oxidative Phosphorylation, Reminiscent of the Warburg Effect in Cancer Cells. Cells 2019; 8(11) doi: 10.3390/cells8111410
|
| 43 |
Franziska Wolter, Andreas Glässner, Benjamin Krämer, Pavlos Kokordelis, Claudia Finnemann, Dominik J. Kaczmarek, Felix Goeser, Philipp Lutz, Hans Dieter Nischalke, Christian P. Strassburg, Ulrich Spengler, Jacob Nattermann. Hypoxia impairs anti-viral activity of natural killer (NK) cells but has little effect on anti-fibrotic NK cell functions in hepatitis C virus infection. Journal of Hepatology 2015; 63(6) doi: 10.1016/j.jhep.2015.08.008
|
| 44 |
Petra Surlin, Dorin Nicolae Gheorghe, Liliana Foia, Amelia Surdu, Vasilica Toma, Sorina Mihaela Solomon, Dan Nicolae Florescu, Ion Rogoveanu. Hepatitis C - From Infection to Cure. 2018; doi: 10.5772/intechopen.76135
|
| 45 |
Kara W. Chew, Chia-Ying Liu, Bharath Ambale-Venkatesh, Diana Liao, Tamara B. Horwich, João A.C. Lima, David A. Bluemke, J. Paul Finn, Adeel A. Butt, Judith S. Currier. Subclinical myocardial disease by cardiac magnetic resonance imaging and spectroscopy in healthy HIV/Hepatitis C virus-coinfected persons. Journal of International Medical Research 2017; 45(6) doi: 10.1177/0300060517708919
|
| 46 |
Claudio M. Fader Kaiser, Patricia S. Romano, M. Cristina Vanrell, Cristian A. Pocognoni, Julieta Jacob, Benjamín Caruso, Laura R. Delgui. Biogenesis and Breakdown of Lipid Droplets in Pathological Conditions. Frontiers in Cell and Developmental Biology 2022; 9 doi: 10.3389/fcell.2021.826248
|
| 47 |
Sheng-Han Wang, Shiou-Hwei Yeh, Pei-Jer Chen. Hepatitis C Virus II. 2016; doi: 10.1007/978-4-431-56101-9_4
|
| 48 |
Yuan-Yuei Chen, Wen-Hui Fang, Chung-Ching Wang, Tung-Wei Kao, Yaw-Wen Chang, Hui-Fang Yang, Chen-Jung Wu, Yu-Shan Sun, Wei-Liang Chen, Umberto Vespasiani-Gentilucci. Increased body fat percentage in patients with hepatitis B and C virus infection. PLOS ONE 2018; 13(7) doi: 10.1371/journal.pone.0200164
|
| 49 |
. 2023; doi: 10.70675/5ef57794zadd0z4289z82c8z02b73afadd55
|
| 50 |
Sara Salehi Hammerstad, Shira Frankel Grock, Hanna J. Lee, Alia Hasham, Nina Sundaram, Yaron Tomer. Diabetes and Hepatitis C: A Two-Way Association. Frontiers in Endocrinology 2015; 6 doi: 10.3389/fendo.2015.00134
|
| 51 |
Anna Linda Zignego, Manuel Ramos-Casals, Clodoveo Ferri, David Saadoun, Luca Arcaini, Dario Roccatello, Alessandro Antonelli, Anne Claire Desbois, Cloe Comarmond, Laura Gragnani, Milvia Casato, Peter Lamprecht, Alessandra Mangia, Athanasios G Tzioufas, Zobair M Younossi, Patrice Cacoub. International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement. Autoimmunity Reviews 2017; 16(5) doi: 10.1016/j.autrev.2017.03.004
|
| 52 |
Ayman Alsebaey, Mostafa Elhelbawy, Wael Abdel-Razek, Mohammed Hashim, Hassan Elshenawy, Imam Waked. HCV treatment with direct acting antivirals improves the insulin sensitivity. Expert Review of Anti-infective Therapy 2019; 17(9) doi: 10.1080/14787210.2019.1653184
|
| 53 |
Ting-ting Gao, Zhao-ling Qin, Hao Ren, Ping Zhao, Zhong-tian Qi. Inhibition of IRS-1 by hepatitis C virus infection leads to insulin resistance in a PTEN-dependent manner. Virology Journal 2015; 12(1) doi: 10.1186/s12985-015-0241-4
|
| 54 |
C. Schnier, S. Wild, Z. Kurdi, C. Povey, D. J. Goldberg, S. J. Hutchinson. Matched population‐based study examining the risk of type 2 diabetes in people with and without diagnosed hepatitis C virus infection. Journal of Viral Hepatitis 2016; 23(8) doi: 10.1111/jvh.12520
|
| 55 |
Ayman Alsebaey, Mostafa Elhelbawy, Imam Waked. Platelets-to-lymphocyte ratio is a good predictor of liver fibrosis and insulin resistance in hepatitis C virus-related liver disease. European Journal of Gastroenterology & Hepatology 2018; 30(2) doi: 10.1097/MEG.0000000000001013
|
| 56 |
M.A. Shawky, A.Q. Mohammed, A.M. Hassan, B.H. Ali, H.M. Moustafa. Insulin resistance in nondiabetic Egyptian patients with chronic hepatitis C virus. Revista de Gastroenterología de México (English Edition) 2020; 85(2) doi: 10.1016/j.rgmxen.2019.05.007
|
| 57 |
Telma E. Silva, Marcelo F. Ronsoni, Leonardo L. Schiavon. Challenges in diagnosing and monitoring diabetes in patients with chronic liver diseases. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2018; 12(3) doi: 10.1016/j.dsx.2017.12.013
|
| 58 |
Marina Angel, Yelena Petrosyan, Mary-Anne Doyle, Curtis Cooper. HCV infection characteristics, treatment uptake and outcomes in patient with diabetes mellitus. BMC Endocrine Disorders 2022; 22(1) doi: 10.1186/s12902-022-01198-x
|
| 59 |
Tram T. Tran, Darshan Mehta, Federico Mensa, Caroline Park, Yanjun Bao, Yuri Sanchez Gonzalez. Pan-Genotypic Hepatitis C Treatment with Glecaprevir and Pibrentasvir for 8 Weeks Resulted in Improved Cardiovascular and Metabolic Outcomes and Stable Renal Function: A Post-Hoc Analysis of Phase 3 Clinical Trials. Infectious Diseases and Therapy 2018; 7(4) doi: 10.1007/s40121-018-0218-x
|
| 60 |
Evangelista Sagnelli, Caterina Sagnelli, Antonio Russo, Mariantonietta Pisaturo, Clarissa Camaioni, Roberta Astorri, Nicola Coppola. Advances in Microbiology, Infectious Diseases and Public Health. Advances in Experimental Medicine and Biology 2020; 1323 doi: 10.1007/5584_2020_604
|
| 61 |
Elena Laura Iliescu, Adriana Mercan-Stanciu, Letitia Toma. Safety and efficacy of direct-acting antivirals for chronic hepatitis C in patients with chronic kidney disease. BMC Nephrology 2020; 21(1) doi: 10.1186/s12882-020-1687-1
|
| 62 |
Safaa R. Askar, Radwa S. Hagag, Moamen A. Ismail, Heba I. Aly. Metabolic syndrome severity z-score in non-diabetic non-obese Egyptian patients with chronic hepatitis c virus infection. Future Journal of Pharmaceutical Sciences 2024; 10(1) doi: 10.1186/s43094-024-00739-6
|
| 63 |
Mahmoud Darweesh, Saeed Mohammadi, Mina Rahmati, Moosa Al-Hamadani, Ahmed Al-Harrasi. Metabolic reprogramming in viral infections: the interplay of glucose metabolism and immune responses. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1578202
|
| 64 |
Ratna B. Ray, Ranjit Ray. Hepatitis C Virus Manipulates Humans as its Favorite Host for a Long‐Term Relationship. Hepatology 2019; 69(2) doi: 10.1002/hep.30214
|
| 65 |
Ni Chen, Yuli Chen, Qiuhong Liu, Ying Shu. Incidence and risk factors of post-transplant diabetes mellitus after kidney transplantation: a systematic review and meta-analysis. Frontiers in Endocrinology 2026; 17 doi: 10.3389/fendo.2026.1838424
|
| 66 |
Nalan Okuroglu, Meltem Sertbas, Ali Ozdemir. Treatment of Chronic Hepatitis C Can Improve Glycemic Control in Patients with Type 2 Diabetes. Case Reports in Hepatology 2018; 2018 doi: 10.1155/2018/5260510
|
| 67 |
Imran Hasanoglu, Antonio Rivero-Juárez, Gülşen Özkaya Şahin. When Metabolic Dysfunction-Associated Steatotic Liver Disease Meets Viral Hepatitis. Journal of Clinical Medicine 2025; 14(10) doi: 10.3390/jcm14103422
|
| 68 |
Shimeng Xu, Xuelin Zhang, Pingsheng Liu. Lipid droplet proteins and metabolic diseases. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(5) doi: 10.1016/j.bbadis.2017.07.019
|
| 69 |
Melania Gaggini, Fabrizia Carli, Chiara Rosso, Ramy Younes, Romina D’Aurizio, Elisabetta Bugianesi, Amalia Gastaldelli. Altered Metabolic Profile and Adipocyte Insulin Resistance Mark Severe Liver Fibrosis in Patients with Chronic Liver Disease. International Journal of Molecular Sciences 2019; 20(24) doi: 10.3390/ijms20246333
|
| 70 |
Stephanie Klein, Jean-François Dufour. Nonalcoholic fatty liver disease and hepatocellular carcinoma. Hepatic Oncology 2017; 4(3) doi: 10.2217/hep-2017-0013
|
| 71 |
G. M. Jeenalieva. THE SIGNS OF CARBOHYDRATE-LIPID METABOLISM DISTURBANCE IN PATIENTS WITH CHRONIC HEPATITIS C. Hepatology and Gastroenterology 2021; 5(1) doi: 10.25298/2616-5546-2021-5-1-56-60
|
| 72 |
Chaoxing Li, Valentin Dinu. miR2Pathway: A novel analytical method to discover MicroRNA-mediated dysregulated pathways involved in hepatocellular carcinoma. Journal of Biomedical Informatics 2018; 81 doi: 10.1016/j.jbi.2018.03.013
|
| 73 |
Ramesh Kumar, Diego García-Compeán, Tanmoy Maji. Hepatogenous diabetes: Knowledge, evidence, and skepticism. World Journal of Hepatology 2022; 14(7): 1291-1306 doi: 10.4254/wjh.v14.i7.1291
|
| 74 |
Jhon Edison Prieto-Ortiz, Nathaly Garzón Orjuela, Santiago Sánchez-Pardo, Robin Germán Prieto-Ortíz, Javier Eslava Schmalbach. Sobrevida en pacientes con cirrosis de acuerdo con su etiología. Cohorte retrospectiva. Revista colombiana de Gastroenterología 2022; 37(1) doi: 10.22516/25007440.703
|
| 75 |
Chien-Hao Huang, Lung-Sheng Wu, Wen-Juei Jeng, Yu-Fu Cheng, Yu-Shien Ko, I-Shyan Sheen, Chun-Yen Lin, Giuseppina Novo. In HCV-related liver cirrhosis, local pulse wave velocity increases and in decompensated patients correlates with poorer survival. PLOS ONE 2019; 14(3) doi: 10.1371/journal.pone.0212770
|
| 76 |
Mei-Yueh Lee, Wei-Chun Chen, Wei-Hao Hsu, Szu-Chia Chen, Jin-Ching Lee. Liraglutide Inhibits Hepatitis C Virus Replication Through an AMP Activated Protein Kinase Dependent Mechanism. International Journal of Molecular Sciences 2019; 20(18) doi: 10.3390/ijms20184569
|
| 77 |
Mostafa Elhelbawy, Wael Abdel-Razek, Ayman Alsebaey, Mohamed Hashim, Hassan Elshenawy, Imam Waked. Insulin resistance does not impair response of chronic hepatitis C virus to direct-acting antivirals, and improves with the treatment. European Journal of Gastroenterology & Hepatology 2019; 31(1) doi: 10.1097/MEG.0000000000001215
|
| 78 |
Josh Reed, Stephen Bain, Venkateswarlu Kanamarlapudi. A Review of Current Trends with Type 2 Diabetes Epidemiology, Aetiology, Pathogenesis, Treatments and Future Perspectives. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021; doi: 10.2147/DMSO.S319895
|
| 79 |
Ines Bilić-Ćurčić, Hrvoje Roguljić, Marul Ivandić, Aleksandar Včev, Robert Smolić, Martina Smolić. Update on Hepatitis C. 2017; doi: 10.5772/intechopen.70721
|
| 80 |
Jonathan G. Stine, Javelle A. Wynter, Blake Niccum, Virginia Kelly, Stephen H. Caldwell, Neeral L. Shah. Effect of Treatment with Direct Acting Antiviral on Glycemic Control in Patients with Diabetes Mellitus and Chronic Hepatitis C. Annals of Hepatology 2017; 16(2) doi: 10.5604/16652681.1231581
|
| 81 |
Takashi Kumada, Hidenori Toyoda, Satoshi Yasuda, Toshifumi Tada, Takanori Ito, Junko Tanaka. Long‐term outcomes of viral eradication in patients with hepatitis C virus infection and mild hepatic fibrosis. Journal of Viral Hepatitis 2021; 28(9) doi: 10.1111/jvh.13562
|
| 82 |
Michał Brzdęk, Dorota Zarębska-Michaluk, Piotr Rzymski, Beata Lorenc, Justyna Janocha-Litwin, Hanna Berak, Krzysztof Tomasiewicz, Marek Sitko, Włodzimierz Mazur, Ewa Janczewska, Dorota Dybowska, Jakub Klapaczyński, Anna Parfieniuk-Kowerda, Jerzy Jaroszewicz, Anna Piekarska, Robert Flisiak. Response to therapy with direct antiviral drugs in HCV-infected patients with diabetes. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-06290-5
|
| 83 |
Alicia Oca�a‑Mondrag�n, Jos� Mata‑Mar�n, Mario Uriarte‑L�pez, Carolina Bekker‑M�ndez, Enrique Alcal�‑Mart�nez, Rosa Ribas‑Aparicio, Luis Uribe‑Nogu�z, Dulce Rodr�guez‑Galindo, Mar�a Mart�nez‑Rodr�guez. Effect of branched‑chain amino acid supplementation on insulin resistance and quality of life in chronic hepatitis C patients. Biomedical Reports 2017; doi: 10.3892/br.2017.1012
|
| 84 |
Kiara Gonçalves Dias Diniz, Diego Alves Vieira, Enrico Antonio Colosimo, Marta Paula Pereira Coelho, Tatiana Bering, Rosangela Teixeira, Maria Isabel Toulson Davidson Correia, Gifone Aguiar Rocha, Luciana Diniz Silva. Derivation and validation of a simple anthropometric equation to predict fat-free mass in patients with chronic hepatitis C. Clinical Nutrition 2021; 40(3) doi: 10.1016/j.clnu.2020.08.011
|
| 85 |
Mashani Mohamad, Sarah Jayne Mitchell, Lindsay Edward Wu, Melanie Yvonne White, Stuart James Cordwell, John Mach, Samantha Marie Solon‐Biet, Dawn Boyer, Dawn Nines, Abhirup Das, Shi‐Yun Catherine Li, Alessandra Warren, Sarah Nicole Hilmer, Robin Fraser, David Andrew Sinclair, Stephen James Simpson, Rafael Cabo, David George Le Couteur, Victoria Carroll Cogger. Ultrastructure of the liver microcirculation influences hepatic and systemic insulin activity and provides a mechanism for age‐related insulin resistance. Aging Cell 2016; 15(4) doi: 10.1111/acel.12481
|
| 86 |
Carlos Esteban Coronel-Castillo, Xingshun Qi, Jocelyn Contreras-Carmona, Oscar Lenin Ramírez-Pérez, Nahum Méndez-Sánchez. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in HIV infection: a metabolic approach of an infectious disease. Expert Review of Gastroenterology & Hepatology 2019; 13(6) doi: 10.1080/17474124.2019.1599284
|
| 87 |
Keke Wu, Shuangqi Fan, Linke Zou, Feifan Zhao, Shengming Ma, Jindai Fan, Xiaowen Li, Mingqiu Zhao, Huichao Yan, Jinding Chen. Molecular Events Occurring in Lipophagy and Its Regulation in Flaviviridae Infection. Frontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.651952
|
| 88 |
Victoria Green, Marina Roytman, Haruki Komatsu. Treatment-Resistant Hepatitis C Viral Infection: A Case Report and Literature Review. Case Reports in Hepatology 2022; 2022 doi: 10.1155/2022/3556780
|